Nishimori H, Nishikawa R, Fujimaki T, Nakagomi T, Matsutani M, Huang H J, Cavenee W K
Ludwig Institute for Cancer Research, San Diego Branch, La Jolla, CA 92093-0660, USA.
J Neurooncol. 2000;46(1):17-22. doi: 10.1023/a:1006404110073.
The PCAF gene encodes the p300/CBP-Associated Factor (PCAF), a histone acetyltransferase, which regulates p53 by acetylation of Lys320 in the C-terminal portion of p53. While the p53 gene is one of the most frequently mutated tumor suppressor genes in human tumors, such mutations occur in only 30% of astrocytic tumors. Since PCAF can regulate p53 activity, abrogation of PCAF function by PCAF gene mutation could be an alternate mechanism to inactivate the p53 pathway in tumors lacking p53 mutations. To test this hypothesis, we determined the nucleotide sequence of the entire PCAF coding region in 37 astrocytic tumors (17 glioblastomas, 10 anaplastic astrocytomas, 7 low-grade astrocytomas, and 3 pilocytic astrocytomas). We detected two single-nucleotide alterations that represented non-deleterious polymorphisms (GAG > GAA Glu103Glu, AAT > AGT Asn386Ser) but no obvious functional mutations. Moreover, the frequency of the Asn386Ser allele that contained Ser386 in glioma patients was not statistically different from its frequency in individuals without disease, and no significant association was observed between the PCAF polymorphisms and the presence or absence of p53 mutations in the tumors. We conclude that the PCAF gene is not mutated during the development of the astrocytic tumors studied here.
PCAF基因编码p300/CBP相关因子(PCAF),一种组蛋白乙酰转移酶,它通过对p53 C末端的赖氨酸320进行乙酰化来调节p53。虽然p53基因是人类肿瘤中最常发生突变的肿瘤抑制基因之一,但此类突变仅在30%的星形细胞瘤中出现。由于PCAF可调节p53活性,PCAF基因突变导致PCAF功能丧失可能是在缺乏p53突变的肿瘤中使p53通路失活的另一种机制。为验证这一假设,我们测定了37例星形细胞瘤(17例胶质母细胞瘤、10例间变性星形细胞瘤、7例低级别星形细胞瘤和3例毛细胞型星形细胞瘤)中整个PCAF编码区的核苷酸序列。我们检测到两个单核苷酸改变,它们代表无有害影响的多态性(GAG > GAA Glu103Glu,AAT > AGT Asn386Ser),但未发现明显的功能突变。此外,胶质瘤患者中含有Ser386的Asn386Ser等位基因频率与无疾病个体的频率在统计学上无差异,且未观察到PCAF多态性与肿瘤中p53突变的存在与否之间存在显著关联。我们得出结论,在此研究的星形细胞瘤发生过程中PCAF基因未发生突变。